DC Chemicals

DC60510 · Updated 28 October 2026

Iso-A11B5C1

Instructions for Use

Before use

Check the supplied lot number, batch COA, approved SDS, quantity and retest date. Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light.

For small quantities of viscous or oily lipid, volumetric transfer can reduce weighing losses. Confirm solvent compatibility and solubility before preparing a stock; calculated volumes do not establish solubility.

Stock-solution planning

Volume (mL) = mass (mg) × 1000 / [molecular weight × concentration (mM)].

Mass10 mM20 mM
10 mg1.5103 mL0.7552 mL
25 mg3.7759 mL1.8879 mL
50 mg7.5517 mL3.7759 mL
100 mg15.1035 mL7.5517 mL

Literature formulation reference

ComponentDC Chemicals productMolecular weightMolar ratioMass at 1 µmol total lipid (mg)
Iso-A11B5C1DC60510662.1600.397260
DOPEDC33634744.03100.074403
CholesterolDCD-041386.65290.112128
C14-PEG2000 (14:0 PEG2000 PE)Not uniquely mappedNot established1Not calculable from disclosed data

Optimized molar composition = 60:10:29:1; ionizable lipid:mRNA = 10:1 by weight. The SI identifies 14:0 PEG2000 PE as the PEG lipid. Its exact commercial product mapping and molecular weight are not assigned here. This is not DMG-PEG2000; total mass fractions remain uncalculated until its molecular weight is specified. N/P was not reported.

Read the complete study conditions, biological results, tolerability and figures →

References

  1. Chen J, Xu Y, Zhou M, et al. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects. PNAS 120, e2309472120 (2023). DOI: 10.1073/pnas.2309472120.
  2. Full text and Supporting Information, Table S2 and Figures S4/S8.